Related Experiment Video
Updated: Jun 28, 2026
16:19
Synthesis, Cellular Delivery and In vivo Application of Dendrimer-based pH Sensors
Published on: September 10, 2013
Dendrimers as versatile platform in drug delivery applications
1Drug Delivery Solutions LLC, Midland, MI 48642, USA. sonkesvenson@att.net
Summary
Dendrimers, a type of nanostructure, show promise for improving drug delivery by overcoming poor solubility and permeability issues. Surface modifications enhance their biocompatibility and enable targeted drug delivery for better patient outcomes.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Pharmaceutical Sciences
Background:
- Many new drugs fail due to poor bioavailability, specifically low water solubility and cell membrane permeability.
- Nanostructures offer potential solutions for drug delivery challenges due to their size and defined properties.
- Dendrimers, with their controllable architecture, are particularly suitable for biomedical applications.
Purpose of the Study:
- To explore the potential of dendrimers as drug delivery vehicles.
- To review methods of drug association with dendrimers and strategies for targeted delivery.
- To discuss the biocompatibility and toxicity considerations of dendrimer-based drug delivery systems.
Main Methods:
- Review of existing literature on dendrimer applications in drug delivery.
- Analysis of drug association methods (physical interactions, prodrug approach).
- Evaluation of targeted delivery strategies (ligand conjugation, EPR effect) and biocompatibility studies.
Main Results:
- Dendrimers can effectively carry various drugs (anticancer, anti-inflammatory, antimicrobial) using poly(amidoamine) (PAMAM), poly(propylene imine) (PPI), and poly(etherhydroxylamine) (PEHAM).
- Targeted drug delivery is achievable through surface functionalization or the enhanced permeability and retention (EPR) effect.
- Surface charge influences cytotoxicity; modifications like PEGylation can mitigate adverse effects.
Conclusions:
- Dendrimers represent a promising nanocarrier platform for improving drug bioavailability and enabling targeted delivery.
- Careful surface modification is crucial for optimizing dendrimer biocompatibility and reducing toxicity.
- Further development of dendrimer-based systems could significantly impact pharmaceutical development and patient treatment.
More Related Videos
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.